相似文献
1
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
Science. 2007 Jun 1;316(5829):1336-41. doi: 10.1126/science.1142364. Epub 2007 Apr 26.
2
Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
Diabetes. 2008 Oct;57(10):2834-42. doi: 10.2337/db08-0047. Epub 2008 Jul 15.
3
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
Science. 2007 Jun 1;316(5829):1341-5. doi: 10.1126/science.1142382. Epub 2007 Apr 26.
4
Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
Diabetes. 2007 Dec;56(12):3105-11. doi: 10.2337/db07-0856. Epub 2007 Sep 7.
5
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
Science. 2007 Jun 1;316(5829):1331-6. doi: 10.1126/science.1142358. Epub 2007 Apr 26.
6
Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.
Diabetes. 2009 Feb;58(2):493-8. doi: 10.2337/db07-1785. Epub 2008 Nov 25.
7
Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population.
BMC Med Genet. 2018 Jun 5;19(1):93. doi: 10.1186/s12881-018-0614-9.
8
Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
J Hum Genet. 2008;53(11-12):991-998. doi: 10.1007/s10038-008-0341-8. Epub 2008 Nov 11.
9
Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians.
Diabetes. 2008 Aug;57(8):2226-33. doi: 10.2337/db07-1583. Epub 2008 May 9.
10
PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.
PLoS One. 2009 Oct 28;4(10):e7643. doi: 10.1371/journal.pone.0007643.
引用本文的文献
1
Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation.
Nat Rev Endocrinol. 2025 Jun 4. doi: 10.1038/s41574-025-01132-w.
2
Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data.
Diabetes. 2025 Jul 1;74(7):1089-1098. doi: 10.2337/db25-0042.
3
IMPlications of IMP2 in RNA Biology and Disease.
Int J Mol Sci. 2025 Mar 7;26(6):2415. doi: 10.3390/ijms26062415.
4
Eperisone Analogs, Rescuers of Defects As a Prokaryotic Homologue of , Suppress Blood Glucose Elevation in Rats.
ACS Med Chem Lett. 2025 Jan 17;16(2):311-316. doi: 10.1021/acsmedchemlett.4c00560. eCollection 2025 Feb 13.
5
Genetic Polymorphism of Zinc Transporter-8 Gene (SLC30A8), Serum Zinc Concentrations, and Proteome Profiles Related to Type 2 Diabetes in Elderly.
J Clin Med. 2025 Jan 25;14(3):790. doi: 10.3390/jcm14030790.
6
Diabetes in China: epidemiology, pathophysiology and multi-omics.
Nat Metab. 2025 Jan;7(1):16-34. doi: 10.1038/s42255-024-01190-w. Epub 2025 Jan 14.
7
Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity.
bioRxiv. 2025 Jan 4:2024.12.30.630732. doi: 10.1101/2024.12.30.630732.
8
Significant association between insulin-like growth factor 2 mRNA-binding protein 2, interleukin-6 polymorphisms, and type 2 diabetes mellitus.
J Res Med Sci. 2024 Nov 28;29:71. doi: 10.4103/jrms.jrms_717_23. eCollection 2024.
9
Significant Association Between Genetic Polymorphism of Insulin-Like Growth Factor-2 mRNA Binding Protein-2 and Type 2 Diabetes Mellitus: A Population-Based Case-Control Study.
J Clin Lab Anal. 2025 Feb;39(3):e25147. doi: 10.1002/jcla.25147. Epub 2025 Jan 3.
10
The Impact of Ancestry on Genome-Wide Association Studies.
Pac Symp Biocomput. 2025;30:251-267. doi: 10.1142/9789819807024_0019.
本文引用的文献
1
A genome-wide association study identifies novel risk loci for type 2 diabetes.
Nature. 2007 Feb 22;445(7130):881-5. doi: 10.1038/nature05616. Epub 2007 Feb 11.
2
p16INK4a induces an age-dependent decline in islet regenerative potential.
Nature. 2006 Sep 28;443(7110):453-7. doi: 10.1038/nature05092. Epub 2006 Sep 6.
3
Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity.
J Biol Chem. 2006 Sep 29;281(39):28858-64. doi: 10.1074/jbc.M604690200. Epub 2006 Aug 3.
4
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
Nat Genet. 2006 Mar;38(3):320-3. doi: 10.1038/ng1732. Epub 2006 Jan 15.
5
A fine-scale map of recombination rates and hotspots across the human genome.
Science. 2005 Oct 14;310(5746):321-4. doi: 10.1126/science.1117196.
6
Cdk5-dependent regulation of glucose-stimulated insulin secretion.
Nat Med. 2005 Oct;11(10):1104-8. doi: 10.1038/nm1299. Epub 2005 Sep 11.
7
Type 2 diabetes: principles of pathogenesis and therapy.
Lancet. 2005;365(9467):1333-46. doi: 10.1016/S0140-6736(05)61032-X.
8
Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex.
Genes Dev. 2005 Feb 1;19(3):387-96. doi: 10.1101/gad.1279405.
9
Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-beta1.
Mol Cell Endocrinol. 2005 Jan 14;229(1-2):175-84. doi: 10.1016/j.mce.2004.08.007.
10
Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
Diabetologia. 2004 Apr;47(4):686-94. doi: 10.1007/s00125-004-1372-0.
Zotero 插件